Carriage of extended-spectrum beta-lactamase-producing enterobacteriacae among internal medicine patients in Switzerland

Antimicrobial Resistance and Infection Control

Volumn 2, Issue 1, 2013, Pages

  Pasricha, Janet ^a,b   Koessler, Thibaud ^a   Harbarth, Stephan ^a   Schrenzel, Jacques ^a   Camus, Véronique ^a   Cohen, Gilles ^a   Perrier, Arnaud ^a   Pittet, Didier ^a   Iten, Anne ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antimicrobial resistance; Extended spectrum beta lactamase producing enterobacteraciae; Infection control

Indexed keywords

AMOXICILLIN; CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; COTRIMOXAZOLE; ERTAPENEM; FLUCLOXACILLIN; IMIPENEM; MACROLIDE; MEROPENEM; METRONIDAZOLE; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ARTICLE; ENTEROBACTERIACEAE INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; INTERNAL MEDICINE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCREENING TEST; SWITZERLAND;

EID: 84890174492     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-2-20     Document Type: Article

References (26)

1. Pena C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA, Calatayud L, Ariza J, Gudiol F. Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect 2006, 12:279-284. 10.1111/j.1469-0691.2005.01358.x, 16451416.
2. Canton R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006, 9:466-475. 10.1016/j.mib.2006.08.011, 16942899.
3. Stewardson A, Fankhauser C, De Angelis G, Rohner P, Safran E, Schrenzel J, Pittet D, Harbarth S. Burden of bloodstream infection caused by extended-spectrum beta-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model. Infect Control Hosp Epidemiol 2013, 34:133-143. 10.1086/669086, 23295559.
4. Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, Nemoy LL, Johnson JK. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Control 2007, 35:97-101. 10.1016/j.ajic.2006.09.011, 17327188.
5. Lowe CF, Katz K, McGeer AJ, Muller MP. Efficacy of admission screening for extended-spectrum Beta-lactamase producing enterobacteriaceae. PLoS One 2013, 8:e62678. 10.1371/journal.pone.0062678, 3637447, 23638132.
6. Gardam MA, Burrows LL, Kus JV, Brunton J, Low DE, Conly JM, Humar A. Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak?. J Infect Dis 2002, 186:1754-1760. 10.1086/345921, 12447761.
7. Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol 2004, 25:838-841. 10.1086/502305, 15518025.
8. Johnson SW, Anderson DJ, May DB, Drew RH. Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum beta-lactamase-producing enterobacteriaceae on hospital admission. Infect Control Hosp Epidemiol 2013, 34:385-392. 10.1086/669858, 23466912.
9. Zahar JR, Lortholary O, Martin C, Potel G, Plesiat P, Nordmann P. Addressing the challenge of extended-spectrum beta-lactamases. Curr Opin Investig Drugs 2009, 10:172-180.
10. Fankhauser C, Zingg W, Francois P, Dharan S, Schrenzel J, Pittet D, Harbarth S. Surveillance of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a Swiss Tertiary Care Hospital. Swiss Med Wkly 2009, 139:747-751.
11. Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009, 49:682-690. 10.1086/604713, 19622043.
12. Han JH, Nachamkin I, Zaoutis TE, Coffin SE, Linkin DR, Fishman NO, Weiner MG, Hu B, Tolomeo P, Lautenbach E. Risk factors for gastrointestinal tract colonization with extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients. Infect Control Hosp Epidemiol 2012, 33:1242-1245. 10.1086/668443, 23143363.
13. Song KH, Jeon JH, Park WB, Park SW, Kim HB, Oh MD, Lee HS, Kim NJ, Choe KW. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC Infect Dis 2009, 9:41. 10.1186/1471-2334-9-41, 2671512, 19361340.
14. Bert F, Larroque B, Paugam-Burtz C, Dondero F, Durand F, Marcon E, Belghiti J, Moreau R, Nicolas-Chanoine MH. Pretransplant fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae and infection after liver transplant, France. Emerg Infect Dis 2012, 18:908-916. 10.3201/eid1806.110139, 3358139, 22607885.
15. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Perea EJ, Perez-Cano R, Hernandez JR, Pascual A. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006, 42:37-45. 10.1086/498519, 16323089.
16. Rooney PJ, O'Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, Badri M, Woodford N, Karisik E, Livermore DM. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 2009, 64:635-641. 10.1093/jac/dkp220, 19549667.
17. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis 2006, 42:925-934. 10.1086/500936, 16511754.
18. Ruppe E, Pitsch A, Tubach F, de Lastours V, Chau F, Pasquet B, Lucet JC, Andremont A, Fantin B. Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards. Eur J Clin Microbiol Infect Dis 2012, 31:319-325. 10.1007/s10096-011-1313-z, 21660500.
19. Buke C, Armand-Lefevre L, Lolom I, Guerinot W, Deblangy C, Ruimy R, Andremont A, Lucet JC. Epidemiology of multidrug-resistant bacteria in patients with long hospital stays. Infect Control Hosp Epidemiol 2007, 28:1255-1260. 10.1086/522678, 17926276.
20. Pena C, Pujol M, Ricart A, Ardanuy C, Ayats J, Linares J, Garrigosa F, Ariza J, Gudiol F. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 1997, 35:9-16. 10.1016/S0195-6701(97)90163-8, 9032631.
21. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, Hebden JN, Morris JG. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007, 13:1144-1149. 10.3201/eid1308.070071, 2828082, 17953083.
22. Azim A, Dwivedi M, Rao PB, Baronia AK, Singh RK, Prasad KN, Poddar B, Mishra A, Gurjar M, Dhole TN. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria-an Indian experience. J Med Microbiol 2010, 59:955-960. 10.1099/jmm.0.018085-0, 20413621.
23. Enoch DA, Brown F, Sismey AW, Mlangeni DA, Curran MD, Karas JA, Cone DB, Aliyu SH, Dhanji H, Doumith M, et al. Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a UK district hospital; an observational study. J Hosp Infect 2012, 81:270-277. 10.1016/j.jhin.2012.05.006, 22742987.
24. Snyder GM, D'Agata EM. Diagnostic accuracy of surveillance cultures to detect gastrointestinal colonization with multidrug-resistant gram-negative bacteria. Am J Infect Control 2012, 40:474-476. 10.1016/j.ajic.2011.06.011, 21925768.
25. Papadomichelakis E, Kontopidou F, Antoniadou A, Poulakou G, Koratzanis E, Kopterides P, Mavrou I, Armaganidis A, Giamarellou H. Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection. Intensive Care Med 2008, 34:2169-2175. 10.1007/s00134-008-1247-9, 18712349.
26. Weintrob AC, Roediger MP, Barber M, Summers A, Fieberg AM, Dunn J, Seldon V, Leach F, Huang XZ, Nikolich MP, Wortmann GW. Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010, 31:330-337. 10.1086/651304, 20175687.